Management of cardiovascular disease in Turner syndrome

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 12, 2009, Pages 1631-1641

  Thomas, Joshua ^a   Yetman, Anji T ^b  

^a UNIVERSITY OF UTAH   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Adulthood; Aortopathy; Cerebrovascular; Diabetes; Dissection; Hyperlipidemia; Hypertension; Obesity; Transition; Turner syndrome

Indexed keywords

ESTROGEN; GROWTH HORMONE;

AORTA COARCTATION; AORTA DISSECTION; AORTA SURGERY; BICUSPID AORTIC VALVE; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONGENITAL HEART MALFORMATION; CORONARY ARTERY DISEASE; DELAYED DIAGNOSIS; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; GENETIC DISORDER; GENETIC VARIABILITY; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOPLASTIC LEFT HEART SYNDROME; LONG TERM CARE; LUNG VEIN DRAINAGE ANOMALY; OBESITY; PREGNANCY DISORDER; REVIEW; RISK FACTOR; TURNER SYNDROME; WOMEN'S HEALTH;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HEART DEFECTS, CONGENITAL; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; PRACTICE GUIDELINES AS TOPIC; TURNER SYNDROME;

EID: 73349118165     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.149     Document Type: Review

References (76)

1. Sybert VP, McCauley E. Turner's syndrome. N. Engl. J. Med. 351(12), 1227-1238 (2004). •• Comprehensive landmark article outlining the many facets of Turner syndrome.
2. Hjerrild BE, Havmand Mortensen K, Gravholt CH. Turner syndrome and clinical treatment. Br. Med. Bull. 86, 77-93 (2008).
3. Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J. Clin. Endocrinol. Metab. 89(12), 5966-5971 (2004).
4. Boucher CA, Sargent CA, Ogata T, Affara NA. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J. Med. Genet. 38, 591-598 (2001). • Provides evidence for genotype-phenotype correlation and rationale behind a possible 'lymphogenetic gene'.
5. Day G, Szvetko A, Griffiths L et al. SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J. Orthop. Res. 27(6), 807-813 (2009).
6. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's Syndrome. J. Pediatrics 133(5), 688-692 (1998). • Provides a comprehensive description of the congenital cardiac defects associated with the syndrome.
7. Völkl TM, Degenhardt K, Koch A, Simm D, Dörr HG, Singer H. Cardiovascular anomalies in children and young adults with Ullrich-Turner syndrome the Erlangen experience. Clin. Cardiol. 28(2), 88-92 (2005).
8. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101(1), 1-7 (1998). •• Comprehensive landmark review outlining the many facets of Turner syndrome.
9. Gotsche CO, Krag-Olsen B, Nielsen J, Sorenson KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch. Dis. Child. 71, 433-436 (1994). • Thorough description of cardiovascular anomalies associated with different genetic karyotypes.
10. Reis PM, Punch MR, Bove EL, Van De Ven CJ. Outcome of infants with hypoplastic left heart and Turner syndromes. Obstet. Gynencol. 93(4), 532-535 (1999).
11. Van Egmond H, Orye E, Praet M, Coppens M, Devloo-Blancquaert A. Hypoplastic left heart syndrome and 45X karyotype. Br. Heart J. 60(1), 69-71 (1988).
12. Ho VB, Bakalov VK, Cooley M et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110, 1694-1700 (2004).
13. Douchin S, Rossignol AM, Klein SK, Siché JP, Baguet JP, Bost M. Heart malformations and vascular complications associated with Turner's syndrome. Prospective study of 26 patients. Arch. Mal Coeur Vaiss. 93(5), 565-570 (2000).
14. Sachdev V, Matura LA, Sidenko S et al. Aortic valve disease in Turner syndrome. J. Am. Coll. Cardiol. 51(19), 1904-1909 (2008). •• Provides a detailed analysis of aortic valve morphology in Turner syndrome and speculates as to a possible genetic basis of associated aortic valve disease.
15. Andersen NH, Hjerrild BE, Sorensen K et al. Sublinical left ventricular dysfunction in normotensive women with Turner syndrome. Heart 92, 1516-1517 (2006).
16. Sozen AB, Cefle K, Kudat H et al. Left ventricular thickness is increased in nonhypertensive Turner's syndrome. Echocardiography. 26(8), 943-949 (2009).
17. Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome? Teratology 29, 355-361 (1984). • Landmark article describing the association between webbed neck and coarctation of the aorta.
18. Anisimov A, Alitalo A, Korpisalo P et al. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ. Res. (104), 1302-1312 (2009).
19. Brandenberg H, Steegers EA, Gittenberger-de-Groot AC. Potential involvement of vascular endothelial growth factor in pathophysiology of Turner syndrome. Med. Hypotheses 65(2), 300-304 (2005).
20. Massa G, Verlinde F, De Schepper J et al. Trends in age at diagnosis of Turner syndrome. Arch. Dis. Child. 90, 267-268 (2005).
21. Gravholt CH. Turner syndrome in adulthood. Horm. Res. 64(2), 86-93 (2005).
22. Stochholm K, Juul S, Knud J, Naeraa RW, and Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrin. Metab. 91(10), 3897-3902 (2006).
23. Ravelo HR, Stephenson LW, Friedman S et al. Coarctation resection in children with Turner's syndrome: a note of caution. J. Thorac. Cardiovasc. Surg. 80(3), 427-430 (1980).
24. Badmanaban B, Mole D, Sarsam MA. Descending aortic dissection post coarctation repair in a patient with Turner's syndrome. J. Card. Surg. 18(2), 153-154 (2003).
25. Fejzic Z, van Oort. Fatal dissection of the descending aorta after implantation of a stent in a 19 year old female with Turner syndrome. Cardiol. Young 15, 529-531 (2005).
26. Prandstraller D, Mazzanti L, Picchio FM et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr. Cardiol. 20(2), 108-112 (1999).
27. Ammash NM, Seward JB, Warnes CA et al. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J. Am. Coll. Cardiol. 29, 1351-1358 (1997).
28. Gravholt CH, Landin-Wilhelmsen K, Stochholm K et al. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol. Young 16, 430-436 (2006).
29. Russo CF, Cannata A, Lanfranconi M, Vitali E, Garatti A, Bonacina E. Is aortic wall generation related to bicuspid aortic valve anatomy in patients with valvular disease? J. Thorac. Cardiovasc. Surg. 36(4), 937-942 (2008).
30. Yetman AT, Graham T. The dilated aorta in patients with congenital cardiac defects. J. Am. Coll. Card. 53(6), 461-467 (2009).
31. Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilation and dissection in Turner syndrome. Circulation 116(5), 1663-1670 (2007). •• Excellent article describing body size indexed aortic diameters in healthy controls and patients with Turner syndrome noting where they diverge.
32. Lopez L, Arheart KL, Colan SD et al. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics (121), e1622-e1627 (2008).
33. Dulac Y, Pienkowski C, Abadir S, Tauber M, Acar P. Cardiovascular abnormalities in Turner's syndrome: what prevention? Arch. Cardiovasc. Dis. 101(7-8), 485-490 (2008).
34. Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J. Med. Genet. (44), 745-749 (2007).
35. Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J. Hypertens. 24(2), 353-360 (2006).
36. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 78(6), 539-552 (2009).
37. Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adopokines and abdominal aortic aneurysm: health in men study. Circulation 116, 2275-2279 (2007).
38. Karakaya O, Barutcu I, Esen AM et al. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase B) concentration and aortic root dilation. Am. J. Hypertens. 19(4), 361-365 (2006).
39. Yetman AT, McCrindle BW. The impact of obesity in patients with Marfan syndrome. Can. J. Cardiol. (2010) (In Press).
40. Mortensen K, Aydin MA, Rybczynski M et al. Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. Am. J. Hypertens. 22(9), 971-979 (2009).
41. Grotenhuis HB, Ottenkamp J, Westenberg JJ, Bax JJ, Kroft LJ, deRoos A. Reduced aortic elasticity and dilatation are associated with aortic regurgitation and left ventricular hypertrophy in nonstenotic bicuspid aortic valve patients. J. Am. Coll. Cardiol. 49(15), 1660-1665 (2007).
42. Van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA. Aortic distensibility and dimensions and the effects of growth hormone treatment in the Turner syndrome. Am. J. Cardiol. 97(11), 1644-1649 (2006).
43. Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM. Stuctural and functional abnormalities of large arteries in the Turner syndrome. Heart 9, 1442-1446 (2005).
44. Ostberg JE, Donald AE, Halcox JPJ, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner syndrome: arterial dilatatioin and intimal thickening without endothelial dysfunction. J. Clin. Endocrinol. Metab. 90(9), 5161-5166 (2005).
45. Kaelba DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics 123(6), 297-304 (2009).
46. Virdis R, Cantu MC, Ghizzoni L et al. Blood pressure behaviour and control in Turner syndrome. Clin. Exp. Hypertens. A 8(405), 787-791 (1986).
47. Lichiardopol C, Mota M, Braicu D, Militaru C, Mixich F. Diabetes mellitus and Turner syndrome. Rom. J. Intern. Med. 45(3), 299-304 (2007).
48. Ding EL, Song Y, Manson JE et al. Sex hormone-binding globulin and risk of Type 2 diabetes in women and men. N. Engl. J. Med. (2009) (Epub ahead of print).
49. Bakalov VK, Cheng C, Zhou J, Bondy CA. X-chormosome gene dosage and the risk of diabetes in Turner syndrome. J. Clin. Endocrinol. Metab. 94(9), 3289-3296 (2009).
50. Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB. Lipid abnormalities in Turner syndrome. J. Pediatr. 126(2), 242-245 (1995). • One of few studies describing dyslipidemia in patients with Turner syndrome.
51. Oya ID, Schoppen S, Lasunción MA et al. Sex hormone-binding globulin levels and metabolic syndrome and its features in adolescents. Pediatr. Diabetes DOI: 10.1111/j.1399-5448.2009.00559.x (2009).
52. Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J. Clin. Endocrin. Metab. 92(1), 10-25 (2007). •• Comprehensive guidelines for multidisciplinary care of patients with Turner syndrome.
53. El-Mansoury M, Berntorp K, Bryman I. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin. Endocrinol. 68(3), 485-490 (2008).
54. Dalla Pozza R, Bechtold S, Urschel S, Netz H, Schwarz HP. QTc interval prolongation in children with Turner syndrome: the results of exercise testing and 24-h ECG. Eur J. Pediatr. 168(1), 59-64 (2009).
55. Swerdlow AJ, Hermon C, Jacobs PA et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann. Hum. Genet. 65, 177-188 (2001).
56. Aligeti VR, Horn HR. Turner's syndrome and coronary artery disease. Am. J. Cardiol. 99(5), 741-742 (2007).
57. Komori H, Matsuishi T, Abe T et al. Turner syndrome and occlusion of the internal carotid artery. J. Child. Neurol. 8(4), 412-415 (1993).
58. Shoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA; United Kingdom Clinical Cytogenetics Group. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J. Clin. Endocrinol. Metab. 93(12), 4735-4742 (2008).
59. Bondy CA, Ceniceros I, Van PL, Bakalov K, Rosing DR. Prolonged Rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics 118 (4), 1220-1225 (2006).
60. Sozen AB, Cefle K, Kudat H et al. Atrial and ventricular arryhthmogenic potential in Turner Syndrome. Pacing Clin. Electrophysiol. 31(9), 1140-1145 (2008).
61. The practice committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil. Steril. (83), 1074-1075 (2005).
62. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288(3), 321-333 (2002). •• Data from the Women's Health Initiative which markedly altered use of hormonereplacement therapy.
63. Harman M, Naftolin F, Brinton EA, Judelson DR. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Ann. NY Acad. Sci. 1052, 43-56 (2005).
64. Harman SM, Brinton EA, Cedars M et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 8(1), 3-12 (2005).
65. Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin. Endocrinol. 49(4), 447-450 (1998). • Provides a good description of the acquired cardiovascular morbidities associated with Turner syndrome.
66. Langrish JP, Mills NL, Bath LE. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 53(5), 805-811 (2009).
67. Koulouri O, Ostberg J, Conway GS. Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin. Endocrinol. 69(2), 306-310 (2008).
68. Bannink EM, van der Palen RL, Mulder PG, de Muick Keizer-Schrama SM. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences. Horm. Res. 71(6), 343-349 (2009).
69. Bondy CA, Van PL, Bakalov VK, Ho VB. Growth hormone treatment and aortic dimensions in Turner syndrome. J. Clin. Endocrinol. Metab. 91(5), 1785-1788 (2006).
70. Bondy CA, Bakalov VK, Lange ED, Ceniceros I. Deficient medical care for adults with the Turner syndrome. Ann. Int. Med. 145(11), 866-867 (2006). •• Provides detailed data on the causes of death in Turner syndrome and how these differ from the general population.
71. Devernay M, Ecosse E, Coste J, Carel JC. Determinants of medical care for young women with Turner syndrome. J. Clin. Endocrinol. Metab. (2009) (Epub ahead of print).
72. Zuckerman-Levin N, Zinder O, Greenberg A, Levin M, Jacob G, Hochberg Z. Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin. Cendocrinol. 64(4), 410-415 (2006).
73. Gordon KJ, Blobe GC. Role of transforming growth factor beta superfamily signaling pathways in human disease. Biochemica Biophysica. Acta 1782, 197-228 (2008).
74. Davies RR, Gallo A, Coady MA et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann. Thorac. Surg. 81(1), 169-177 (2006).
75. Parish LM, Gorman JH, Kahn S et al. Aortic size in acute type A dissection: implications for preventive ascending aortic replacement. Eur. J. Cardiothorac. Surg. 35(6), 941-945 (2009).
76. Orliaguet O, Pepin JL, Bettega G, Ferretti G, Mignotte HN, Levy P. Sleep apnoea and Turner's syndrome. Eur. Resp. J. 17, 153-155 (2001).